Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
Cristina Zuccato, Lucia Carmela Cosenza, Matteo Zurlo, et al.
Therapeutic Advances in Hematology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic
Roberto Gambari, Maria Rita Gamberini, Lucia Carmela Cosenza, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 1, pp. 289-289
Open Access
Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management
Joanne Traeger‐Synodinos, Christina Vrettou, Christalena Sofocleous, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3400-3400
Open Access | Times Cited: 3
Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications
Roberto Gambari, Aliyu Dahiru Waziri, H. W. W. Goonasekera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4263-4263
Open Access | Times Cited: 3
Effects of Sirolimus treatment on patients with β‐Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells
Matteo Zurlo, Francesco Nicoli, Davide Proietto, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 353-364
Open Access | Times Cited: 9
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy
Matteo Zurlo, Jessica Gasparello, Lucia Carmela Cosenza, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 556-556
Open Access | Times Cited: 7
Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
Alessia Finotti, Roberto Gambari
Frontiers in Genome Editing (2023) Vol. 5
Open Access | Times Cited: 7
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs
Marco Prosdocimi, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Wellcome Open Research (2022) Vol. 7, pp. 150-150
Open Access | Times Cited: 11
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
Matteo Zurlo, Cristina Zuccato, Lucia Carmela Cosenza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15049-15049
Open Access | Times Cited: 6
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs
Marco Prosdocimi, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Wellcome Open Research (2022) Vol. 7, pp. 150-150
Open Access | Times Cited: 8
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin
Lucia Carmela Cosenza, Cristina Zuccato, Matteo Zurlo, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1727-1727
Open Access | Times Cited: 8
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers
Cristina Zuccato, Lucia Carmela Cosenza, Matteo Zurlo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 776-776
Open Access | Times Cited: 4
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies
Roberto Gambari, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1202-1202
Open Access | Times Cited: 4
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients
Cristina Zuccato, Lucia Carmela Cosenza, Chiara Tupini, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 8-8
Open Access | Times Cited: 4
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia
Jyoti Shaw, Abhilipsa Patra, Anjumana Khatun, et al.
eJHaem (2024) Vol. 5, Iss. 3, pp. 440-446
Open Access | Times Cited: 1
AZD8055 Is More Effective Than Rapamycin in Inhibiting Proliferation and Promoting Mitochondrial Clearance in Erythroid Differentiation
Qian Liu, Tao Hao, ZiXuan Lin, et al.
Analytical Cellular Pathology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Activating transcription factor 4 in erythroid development and $$\beta $$-thalassemia: a powerful regulator with therapeutic potential
Jingmin Li, Aixiang Lv, Meihuan Chen, et al.
Annals of Hematology (2023) Vol. 103, Iss. 8, pp. 2659-2670
Closed Access | Times Cited: 3
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia
Lucia Carmela Cosenza, Giovanni Marzaro, Matteo Zurlo, et al.
Experimental Hematology (2023) Vol. 129, pp. 104128-104128
Open Access | Times Cited: 3
Therapeutic Relevance of Inducing Autophagy in β-Thalassemia
Roberto Gambari, Alessia Finotti
Cells (2024) Vol. 13, Iss. 11, pp. 918-918
Open Access
Lost in translation
Laurie A. Steiner
Blood (2024) Vol. 144, Iss. 6, pp. 595-597
Closed Access
Exploring Functional and Immune Contexture in E-Beta Thalassemia Patients Through RNA Sequencing of Peripheral Blood Mononuclear Cells
Nibedita Mitra, Prosanto Chowdhury, Anupam Basu
Heliyon (2024) Vol. 11, Iss. 1, pp. e41255-e41255
Open Access
Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder
Aurelio Maggio, Mariasanta Napolitano, Alì Taher, et al.
British Journal of Haematology (2024)
Closed Access
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)
Matteo Zurlo, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2479-2479
Open Access
Exploring Drug-Drug Interactions: A Network Analysis and Visualization Approach
İlhan Uysal, Utku Köse
Journal of Materials and Mechatronics A (2023) Vol. 4, Iss. 1, pp. 257-270
Open Access
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
Maria Rita Gamberini, Cristina Zuccato, Matteo Zurlo, et al.
Hematology Reports (2023) Vol. 15, Iss. 3, pp. 432-439
Open Access
Conventional and Innovative Molecular Approaches Developed for Treating Hemoglobinopathies
Αndroulla N. Miliotou, Sofia K. Georgiou‐Siafis, Efthymia Vlachaki, et al.
Elsevier eBooks (2023), pp. 202-232
Closed Access
Page 1

Scroll to top